CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Millions	Total	Total Dentsply Sirona Equity	Common Stock	Capital in Excess of Par Value	(Accumulated Deficit) Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock	Noncontrolling Interests
Beginning Balance at Dec. 31, 2022	$ 3,812	$ 3,811	$ 3	$ 6,629	$ 456	$ (628)	$ (2,649)	$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(23)	(19)			(19)			(4)
Other comprehensive (loss) income	14	14				14
Stock-based compensation expense	17	17		17
Funding of employee stock purchase plan	3	3					3
Accelerated share repurchase	(151)	(151)		(30)			(121)
Restricted stock unit distributions	(4)	(4)		(12)			8
Cash dividends	(30)	(30)			(30)
Ending Balance at Mar. 31, 2023	3,638	3,641	3	6,604	407	(614)	(2,759)	(3)
Beginning Balance at Dec. 31, 2022	3,812	3,811	3	6,629	456	(628)	(2,649)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(204)
Other comprehensive (loss) income	(29)
Ending Balance at Sep. 30, 2023	3,371	3,375	3	6,645	167	(657)	(2,783)	(4)
Beginning Balance at Mar. 31, 2023	3,638	3,641	3	6,604	407	(614)	(2,759)	(3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	85	86			86			(1)
Other comprehensive (loss) income	(6)	(6)				(6)
Exercise of stock options	1	1					1
Stock-based compensation expense	14	14		14
Accelerated share repurchase	0			30			(30)
Restricted stock unit dividends	(1)	(1)			(1)
Cash dividends	(29)	(29)			(29)
Ending Balance at Jun. 30, 2023	3,702	3,706	3	6,648	463	(620)	(2,788)	(4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(266)	(266)			(266)
Other comprehensive (loss) income	(37)	(37)				(37)
Stock-based compensation expense	2	2		2
Funding of employee stock purchase plan	2	2		(1)			3
Restricted stock unit distributions	(2)	(2)		(4)			2
Cash dividends	(30)	(30)			(30)
Ending Balance at Sep. 30, 2023	3,371	3,375	3	6,645	167	(657)	(2,783)	(4)
Beginning Balance at Dec. 31, 2023	3,294	3,293	3	6,643	205	(636)	(2,922)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	17	18			18			(1)
Other comprehensive (loss) income	(30)	(30)				(30)
Stock-based compensation expense	11	11		11
Funding of employee stock purchase plan	3	3					3
Restricted stock unit distributions	(4)	(4)		(15)			11
Cash dividends	(33)	(33)			(33)
Ending Balance at Mar. 31, 2024	3,258	3,258	3	6,639	190	(666)	(2,908)	0
Beginning Balance at Dec. 31, 2023	3,294	3,293	3	6,643	205	(636)	(2,922)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(482)
Other comprehensive (loss) income	(2)
Ending Balance at Sep. 30, 2024	2,490	2,491	3	6,639	(374)	(638)	(3,139)	(1)
Beginning Balance at Mar. 31, 2024	3,258	3,258	3	6,639	190	(666)	(2,908)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(4)	(4)			(4)
Other comprehensive (loss) income	(11)	(11)				(11)
Stock-based compensation expense	12	12		12
Treasury shares purchased	(152)	(152)					(152)
Restricted stock unit distributions	(5)	(5)		(20)			15
Cash dividends	(34)	(34)			(34)
Ending Balance at Jun. 30, 2024	3,064	3,064	3	6,631	152	(677)	(3,045)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(495)	(494)			(494)			(1)
Other comprehensive (loss) income	39	39				39
Stock-based compensation expense	12	12		12
Funding of employee stock purchase plan	3	3		(2)			5
Treasury shares purchased	(101)	(101)					(101)
Restricted stock unit distributions	(1)	(1)		(3)			2
Restricted stock unit dividends	0			1	(1)
Cash dividends	(31)	(31)			(31)
Ending Balance at Sep. 30, 2024	$ 2,490	$ 2,491	$ 3	$ 6,639	$ (374)	$ (638)	$ (3,139)	$ (1)